Anne Samuel
Stock Analyst at JP Morgan
(3.17)
# 1,032
Out of 4,765 analysts
62
Total ratings
48.78%
Success rate
1.08%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Overweight | $13 → $12 | $9.54 | +25.79% | 12 | Mar 10, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $240 → $232 | $181.43 | +27.87% | 6 | Feb 18, 2025 | |
| PGNY Progyny | Maintains: Neutral | $17 → $23 | $19.84 | +15.93% | 7 | Jan 28, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $208 → $218 | $227.80 | -4.30% | 5 | Dec 16, 2024 | |
| DOCS Doximity | Maintains: Neutral | $30 → $48 | $60.80 | -21.05% | 5 | Nov 21, 2024 | |
| OMCL Omnicell | Maintains: Neutral | $37 → $44 | $32.28 | +36.31% | 4 | Nov 21, 2024 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $25.45 | +10.02% | 2 | Sep 9, 2024 | |
| PINC Premier | Maintains: Neutral | $21 → $19 | $17.97 | +5.73% | 4 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $23.43 | -10.37% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $4.11 | +216.30% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $35.27 | -23.45% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $2.59 | +93.05% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $86 → $108 | $93.97 | +14.93% | 8 | Apr 2, 2024 |
Evolent Health
Mar 10, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $9.54
Upside: +25.79%
IQVIA Holdings
Feb 18, 2025
Maintains: Overweight
Price Target: $240 → $232
Current: $181.43
Upside: +27.87%
Progyny
Jan 28, 2025
Maintains: Neutral
Price Target: $17 → $23
Current: $19.84
Upside: +15.93%
Veeva Systems
Dec 16, 2024
Maintains: Neutral
Price Target: $208 → $218
Current: $227.80
Upside: -4.30%
Doximity
Nov 21, 2024
Maintains: Neutral
Price Target: $30 → $48
Current: $60.80
Upside: -21.05%
Omnicell
Nov 21, 2024
Maintains: Neutral
Price Target: $37 → $44
Current: $32.28
Upside: +36.31%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $25.45
Upside: +10.02%
Premier
Sep 9, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $17.97
Upside: +5.73%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $23.43
Upside: -10.37%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $4.11
Upside: +216.30%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $35.27
Upside: -23.45%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $2.59
Upside: +93.05%
Apr 2, 2024
Maintains: Overweight
Price Target: $86 → $108
Current: $93.97
Upside: +14.93%